Search Results for " Axitinib "
Axitinib Related Products
Axitinib is a tyrosine kinase inhibitor (TKI) that is primarily used as a targeted therapy in the treatment of renal cell carcinoma (RCC), a type of kidney cancer. It works by blocking the activity of certain enzymes (receptors), known as vascular endothelial growth factor receptors (VEGFR).
SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Axitinib, pharmacopeial and non-pharmacopeial Axitinib impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Axitinib impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.
Axitinib-related products are thoroughly characterized. Axitinib products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.